Afatinib overcoming resistance to icotinib and osimertinib in NSCLC with leptomeningeal metastasis in patients with acquired EGFR L858R/T790M or L858R/S768I mutations: Two case reports
2023 · Heliyon · 4 citations
https://doi.org/10.1016/j.heliyon.2023.e20690